Chief Financial Officer · Experience: Alexion Pharmaceuticals, Inc. Mar 28, 2017 · Alexion had been left in leadership limbo for the beginning of the year, as former CEO and CFO left under a cloud regarding sales practices under the their leadership, but has now found a new CEO: Ludwig Hantson, formerly of Baxalta. Free copies of these documents may be obtained as described in the paragraphs above. Mar 27, 2017 · Alexion Pharma, Still Recovering From Boardroom Troubles, Appoints New CEO Ludwig Hantson takes over the top Alexion job after serving as CEO of Baxalta, which he helped sell to Shire for $32 billion. Media Dec 24, 2025 · Marc Dunoyer is CEO:Alexion/Chief Strategy Officer at Astrazeneca PLC. She succeeded Paul Clancy as CFO in 2019. · Education: University of Waikato · Location: Newton Centre · 500+ connections on LinkedIn. The company also said Chief Director, Strategy & Transformation · At Alexion Pharmaceuticals, my role as Chief of Staff to the CFO encompasses spearheading strategic initiatives, aligning leadership within finance, and Alexion Pharmaceuticals has fired its CEO and CFO as an ongoing investigation into sales practices continues. Alexion Pharmaceuticals, Inc. Jun 14, 2017 · Anyone concerned about a lack of biotech experience coming over with new Alexion CEO Ludwig Hantson and his exec picks won’t have to worry when it comes to his latest addition. | Alexion’s Dec 12, 2020 · Information about the directors and executive officers of Alexion and their ownership of Alexion shares is set forth in the definitive proxy statement for Alexion’s 2020 special meeting of shareholders, as previously filed with the SEC on March 26, 2020. Alexion CFO Aradhana Sarin will become the new finance chief of AstraZeneca after the deal closes, while current AstraZeneca CFO Marc Dunoyer will become Alexion’s top executive and take on a chief strategy role at the giant drugmaker. View Sean Christie’s profile Dec 12, 2016 · Alexion still hasn’t wrapped up its internal investigation of a former employee’s sales fraud allegations. Sep 18, 2019 · Alexion is losing an executive credited with helping the company rebuild trust with investors, and analysts aren't sure why. View Fred Chereau’s profile on LinkedIn, a Dec 12, 2016 · Alexion Pharmaceuticals Inc, which is investigating allegations regarding some of its sales practices over its flagship drug, said its chief executive officer and chief financial officer resigned Jul 14, 2021 · To prepare for the combination, AstraZeneca and Alexion have made plans to shuffle their leadership. Jun 4, 2021 · By Mark Maurer AstraZeneca PLC appointed an Alexion Pharmaceuticals Inc. Other executives include Soraya Bekkali, Senior Vice President, International Commercial Operations; Seng H. Sep 17, 2019 · Alexion Pharmaceuticals, Inc. SVP, Strategy and Business Development at Alexion · Experience: Alexion Pharmaceuticals, Inc. Previously, Fred served as the president and chief operating officer of aTyr Pharma Inc. Hantson led Baxalta’s successful spin-off as a public company Jun 2, 2017 · Alexion’s new CEO has quickly brought in some new people, including more former Baxalta colleagues, to fill the puzzle piece holes left after his executive clean sweep last week. com. BioSpace Have questions about AstraZeneca CEO of Alexion & Chief Strategy Officer Marc Dunoyer? View Mr. The org chart of Alexion Pharmaceuticals contains its 47 main executives like Marc Dunoyer, Scott Weintraub and Tamar Thompson. While Clancy was Alexion's CFO for just two years, the executive Jun 4, 2021 · Hantson joined Alexion in 2017, as did Sarin and former AstraZeneca CEO David Brennan, to regain investor confidence after its top executives left amid an internal investigation over sales of Jun 4, 2021 · With AstraZeneca's Alexion buyout due to close later this year, the British Big Pharma is summoning the rare disease specialist's chief financial officer to its C-suite and tapping a new CEO for Up-to-date Alexion Pharmaceuticals Inc company overview including funding information, company profile, key statistics, peer comparison and more. In July 2015, Dr. (NASDAQ:ALXN) today announced plans for the transition of Executive Vice President and Chief Financial Officer Paul Clancy later this year. (NASDAQ: ALXN) announced today that it has named David Brennan as Interim Chief Executive Officer, effective immediately. 6% to $111. employs 5,511 employees. Hantson was formerly Chief Executive Officer of Alexion Pharmaceuticals, Inc. Sep 18, 2019 · When Paul Clancy jumped ship from Biogen to become Alexion’s chief financial officer in 2017, he was touted as a “careful steward” by top brass. Jun 4, 2021 · AstraZeneca appointed an Alexion Pharmaceuticals executive as its new finance chief as the Covid-19 vaccine maker works to complete the acquisition of the company.